Robert B. Innis

Active 1979–2025

168
Papers
30,811
Citations
100
h-index
154
i10-index

Citations

Citations per year for Robert B. Innis1932: 1 citations1978: 1 citations1979: 1 citations1980: 4 citations1981: 11 citations1982: 7 citations1983: 16 citations1984: 10 citations1985: 12 citations1986: 10 citations1987: 6 citations1988: 9 citations1989: 9 citations1990: 23 citations1991: 16 citations1992: 14 citations1993: 36 citations1994: 35 citations1995: 51 citations1996: 59 citations1997: 138 citations1998: 119 citations1999: 201 citations2000: 246 citations2001: 283 citations2002: 317 citations2003: 322 citations2004: 309 citations2005: 348 citations2006: 340 citations2007: 390 citations2008: 358 citations2009: 409 citations2010: 344 citations2011: 315 citations2012: 359 citations2013: 291 citations2014: 293 citations2015: 315 citations2016: 279 citations2017: 265 citations2018: 212 citations2019: 628 citations2020: 612 citations2021: 662 citations2022: 465 citations2023: 309 citations2024: 478 citations2025: 228 citations2026: 5 citations1933–1977: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,489 citing papers, 34.6% of this breakdownUnited Kingdom: 869 citing papers, 8.6% of this breakdownGermany: 646 citing papers, 6.4% of this breakdownCanada: 559 citing papers, 5.5% of this breakdownChina: 363 citing papers, 3.6% of this breakdownFrance: 356 citing papers, 3.5% of this breakdownItaly: 355 citing papers, 3.5% of this breakdownNetherlands: 349 citing papers, 3.5% of this breakdownSweden: 335 citing papers, 3.3% of this breakdownJapan: 266 citing papers, 2.6% of this breakdownAustralia: 252 citing papers, 2.5% of this breakdownSwitzerland: 227 citing papers, 2.3% of this breakdown
0%34.6%Other 20.1%

Fields

  • Medicine43.7%
  • Neuroscience37.5%
  • Psychology8.6%
  • Biochemistry, Genetics and Molecular Biology6.9%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Immunology and Microbiology0.5%
  • Other2.2%

Topics

  • Neurotransmitter Receptor Influence on Behavior7.2%
  • Neuroscience and Neuropharmacology Research5.5%
  • Stress Responses and Cortisol3.7%
  • Parkinson's Disease Mechanisms and Treatments3.3%
  • Tryptophan and brain disorders3.2%
  • Functional Brain Connectivity Studies3.2%
  • Other73.9%

Coauthors

All papers

Open in search
  1. PET imaging of neuroinflammation in neurological disorders

    Authors: , , , , , - The Lancet Neurology 2020 cited by 237

  2. Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Cerebral Blood Flow & Metabolism 2007 cited by 1,985

  3. Neuroinflammation in psychiatric disorders: PET imaging and promising new targets

    Authors: , , , , , - The Lancet Psychiatry 2020 cited by 266

  4. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer’s disease

    Authors: , , , , , , , , , , , , - Brain 2013 cited by 348

  5. Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein

    Authors: , , , , , , , , - Journal of Nuclear Medicine 2015 cited by 238

  6. Image-Derived Input Function for Brain PET Studies: Many Challenges and Few Opportunities

    Authors: , , , , - Journal of Cerebral Blood Flow & Metabolism 2011 cited by 283

  7. 11C-ER176, a Radioligand for 18-kDa Translocator Protein, Has Adequate Sensitivity to Robustly Image All Three Affinity Genotypes in Human Brain

    Authors: , , , , , , , , , , - Journal of Nuclear Medicine 2016 cited by 191

  8. MRI-based measurement of hippocampal volume in patients with combat- related posttraumatic stress disorder

    Authors: , , , , , , , , , - American Journal of Psychiatry 1995 cited by 1,611

  9. PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects

    Authors: , , , , , , , , , , , , , , , - EJNMMI Research 2018 cited by 183

  10. The past, present, and future of the brain imaging data structure (BIDS)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Oscar Estéban, Franklin Feingold, Guillaume Flandin, Anthony Galassi, Giuseppe Gallitto, Melanie Ganz, Rémi Gau, James Gholam, Satrajit Ghosh, Alessio Giacomel, Ashley Gillman, Padraig Gleeson, Alexandre Gramfort, Samuel Guay, Giacomo Guidali, Yaroslav O. Halchenko, Daniel A. Handwerker, Nell Hardcastle, Peer Herholz, Dora Hermes, Christopher J. Honey, Robert B. Innis, Horea-Ioan Ioanas, Andrew Jahn, Agâh Karakuzu, David B. Keator, Gregory Kiar, Bálint Kincses, Angela R. Laird, Jonathan C. Lau, Alberto Lazari, Jon Haitz Legarreta, Adam Li, Xiangrui Li, Bradley C. Love, Hanzhang Lu, Eleonora Marcantoni, Camille Maumet, Giacomo Mazzamuto, Steven L. Meisler, Mark E. Mikkelsen, Henk Mutsaerts, Thomas E. Nichols, Aki Nikolaidis, Gustav Nilsonne, Guiomar Niso, Martin Norgaard, Thomas W. Okell, Robert Oostenveld, Eduard Ort, Patrick J. Park, Mateusz Pawlik, Cyril Pernet, Franco Pestilli, Jan Petr, Christophe Phillips, Jean‐Baptiste Poline, Luca Pollonini, Pradeep Reddy Raamana, Petra Ritter, Gaia Rizzo, Kay A. Robbins, Alexander P. Rockhill, Christine Rogers, Ariel Rokem, Chris Rorden, Alexandre Routier, Jose Manuel Saborit-Torres, Taylor Salo, Michael Schirner and 15 more - Imaging Neuroscience 2024 cited by 52

  11. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.

    Authors: , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1996 cited by 1,294

  12. Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance

    Authors: , , , , , , , , , , , , , , , , - Cell Metabolism 2012 cited by 348

  13. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers

    Authors: , , , , , , , , , - Molecular Psychiatry 2011 cited by 584

  14. Comparison of [11C]-(R)-PK 11195 and [11C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker

    Authors: , , , , , , , , , , , , , - NeuroImage 2009 cited by 274

  15. 11C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease

    Authors: , , , , , , , , , , , - Neurobiology of Aging 2016 cited by 175

  16. Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein

    Authors: , , , , , , , , , , , , , , , - JAMA Neurology 2015 cited by 166

  17. Linearized Reference Tissue Parametric Imaging Methods: Application to [ 11 C]DASB Positron Emission Tomography Studies of the Serotonin Transporter in Human Brain

    Authors: , , , , , , , , , - Journal of Cerebral Blood Flow & Metabolism 2003 cited by 677

  18. Increased Striatal Dopamine Transmission in Schizophrenia: Confirmation in a Second Cohort

    Authors: , , , , , , , , , - American Journal of Psychiatry 1998 cited by 803

  19. A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation

    Authors: , , , , , , , , , , , - Journal of Cerebral Blood Flow & Metabolism 2012 cited by 252

  20. Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB1R) Antagonist

    Authors: , , , , , , , , , , , , , , , - ACS Pharmacology & Translational Science 2021 cited by 60

  21. Mixed-Affinity Binding in Humans with 18-kDa Translocator Protein Ligands

    Authors: , , , , , , , , , , - Journal of Nuclear Medicine 2010 cited by 354

  22. Decreased single‐photon emission computed tomographic 123Iβ‐CIT striatal uptake correlates with symptom severity in parkinson's disease

    Authors: , , , , , , , , , , , - Annals of Neurology 1995 cited by 467

  23. The Inhibitor Ko143 Is Not Specific for ABCG2

    Authors: , , , , , , , , , - Journal of Pharmacology and Experimental Therapeutics 2015 cited by 137

  24. Increased dopamine transmission in schizophrenia: relationship to illness phases

    Authors: , , , , - Biological Psychiatry 1999 cited by 712